Invention Grant
- Patent Title: Benzoimidazol-1,2-yl amides as Kv7 channel activators
-
Application No.: US16460449Application Date: 2019-07-02
-
Publication No.: US10906877B2Publication Date: 2021-02-02
- Inventor: Lynn Resnick , George T. Topalov , Justin K. Belardi , James S. Hale , Scott S. Harried , Charles A. Flentge , David A. Mareska
- Applicant: KNOPP BIOSCIENCES LLC
- Applicant Address: US PA Pittsburgh
- Assignee: KNOPP BIOSCIENCES LLC
- Current Assignee: KNOPP BIOSCIENCES LLC
- Current Assignee Address: US PA Pittsburgh
- Agency: Troutman Pepper Hamilton Sanders LLP
- Main IPC: C07D235/30
- IPC: C07D235/30 ; C07D413/04 ; C07D401/04 ; C07D405/12 ; C07D403/04 ; C07D401/12
Abstract:
Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.
Public/Granted literature
- US20200002292A1 BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS Public/Granted day:2020-01-02
Information query
